EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Autoantibodies to Interferons in Infectious Diseases

Eugenia Quiros-Roldan iD, Alessandra Sottini iD, Simona Giulia Signorini iD, Federico Serana, Giorgio Tiecco iD, Luisa Imberti iD

Viruses · 22.05.2023 · 15 (5) · 1215

DOI: 10.3390/v15051215 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 22.05.2023. Verfasst von Eugenia Quiros-Roldan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious and Tropical Diseases, ASST Spedali Civili, Brescia and University of Brescia, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Autoimmune Diseases, COVID-19, Interferon Type I, Communicable Diseases. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-cytokine autoantibodies and, in particular, anti-type I interferons are increasingly described in association with immunodeficient, autoimmune, and immune-dysregulated conditions. Their presence in otherwise healthy individuals may result in a phenotype characterized by a predisposition to infections with several agents. For instance, anti-type I interferon autoantibodies are implicated in Coronavirus Disease 19 (COVID-19) pathogenesis and found preferentially in patients with critical disease. However, autoantibodies were also described in the serum of patients with viral, bacterial, and fungal infections not associated with COVID-19. In this review, we provide an overview of anti-cytokine autoantibodies identified to date and their clinical associations; we also discuss whether they can act as enemies or friends, i.e., are capable of acting in a beneficial or harmful way, and if they may be linked to gender or immunosenescence. Understanding the mechanisms underlying the production of autoantibodies could improve the approach to treating some infections, focusing not only on pathogens, but also on the possibility of a low degree of autoimmunity in patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesCOVID-19Interferon Type ICommunicable DiseasesHumansAutoantibodiesInterferonsCytokines

Stichwörter der Autor:innen

COVID-19antiviral immunityautoantibodiescytokinesinterferons

Substanzen

AutoantibodiesInterferonsCytokinesInterferon Type I

Autor:innen und Institutionen

  • Department of Infectious and Tropical Diseases, ASST Spedali Civili, Brescia and University of Brescia, 25123 Brescia, Italy.
  • Clinical Chemistry Laboratory, ASST Spedali Civili of Brescia, 25123 Brescia, Italy.
  • Section of Microbiology, University of Brescia, P. le Spedali Civili, 1, 25123 Brescia, Italy.

ORCID-Profile: Eugenia Quiros-Roldan, Alessandra Sottini, Simona Giulia Signorini, Giorgio Tiecco, Luisa Imberti

Zitieren

APA

Quiros-Roldan, E., Sottini, A., Signorini, S. G., Serana, F., Tiecco, G., & Imberti, L. (2023). Autoantibodies to Interferons in Infectious Diseases. Viruses, 15(5), 1215. https://doi.org/10.3390/v15051215

Vancouver

Quiros-Roldan E, Sottini A, Signorini SG, Serana F, Tiecco G, Imberti L. Autoantibodies to Interferons in Infectious Diseases. Viruses. 2023;15(5):1215. doi:10.3390/v15051215

BibTeX
@article{QuirosRoldan2023,
  author = {Quiros-Roldan, Eugenia and Sottini, Alessandra and Signorini, Simona Giulia and Serana, Federico and Tiecco, Giorgio and Imberti, Luisa},
  title = {Autoantibodies to Interferons in Infectious Diseases},
  journal = {Viruses},
  year = {2023},
  volume = {15},
  number = {5},
  pages = {1215},
  doi = {10.3390/v15051215}
}
Kostenlos starten →